FindTrial
Sign In

Retrospective study on the prognostic factors influencing the overall survival of patients with colorectal cancer liver metastasis

Retrospective study on the prognostic factors influencing the overall survival of patients with colorectal cancer liver metastasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066786
Enrollment
Unknown
Registered
2022-12-16
Start date
2022-12-20
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Single group:None

Sponsors

Guang’anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients with colorectal cancer confirmed by pathological or cytological tests, and with liver metastases confirmed by pathological test or imaging examination; 2. Receiving Chinese medicine treatment (including Chinese medicine decoction, Chinese medicine injection, Chinese patent medicine, and Chinese medicine external application), the duration of Chinese medicine treatment = 3 months; 3. Patients with survival time = 3 months; 4. Age = 18 years old; 5. Follow-up is available.

Exclusion criteria

Exclusion criteria: (1) Patients with colorectal cancer not confirmed by pathology or cytology. (2) Combined other malignant tumors. (3) Incomplete information.

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Countries

China

Contacts

Public ContactJie Li

Guang’anmen Hospital, China Academy of Chinese Medical Sciences

qfm2020jieli@yeah.net010-88001711

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026